NYSE: CECelanese Corp Stock
$45.24+2.13 (+4.94%)
Updated Aug 19, 2025
CE Price
$45.24
Fair Value Price
N/A
Market Cap
$4.95B
52 Week Low
$36.29
52 Week High
$142.54
P/E
-3.05x
P/B
0.94x
P/S
0.61x
PEG
N/A
Dividend Yield
1.75%
Revenue
$9.94B
Earnings
-$1.62B
Gross Margin
21.9%
Operating Margin
-5.63%
Profit Margin
-16.3%
Debt to Equity
3.41
Operating Cash Flow
$1B
Beta
1.25
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CE Overview
Celanese Corporation produces 25% of the annual global production of acetic acid. It is also the world's largest producer of vinyl acetate monomer. Celanese operates 25 production plants and six research centers in 11 countries. Formerly known as Hoechst Celanese, the company was founded in 1918 and is headquartered in Irving, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Chemical
Industry Rating
F
CE
Ranked#4 of 15
Ranked#4 of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $21.82 | C | |
| $55.96 | C | |
| $7.68 | C |
Be the first to know about important CE news, forecast changes, insider trades & much more!
CE News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CE is good value based on its book value relative to its share price (0.94x), compared to the US Chemicals industry average (0.98x)
P/B vs Industry Valuation
CE is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more CE due diligence checks available for Premium users.
Valuation
CE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.05x
Industry
-8.12x
Market
35.19x
CE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.94x
Industry
0.98x
CE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CE's financial health
Profit margin
Revenue
$2.5B
Net Income
$199.0M
Profit Margin
7.9%
CE's Earnings (EBIT) of -$560.00M... subscribe to Premium to read more.
Interest Coverage Financials
CE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$23.7B
Liabilities
$18.0B
Debt to equity
3.41
CE's short-term assets ($5.68B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CE's long-term liabilities ($15.24B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CE's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$410.0M
Investing
-$88.0M
Financing
-$116.0M
CE's operating cash flow ($1.02B)... subscribe to Premium to read more.
Debt Coverage Financials
CE vs Chemical Stocks
Celanese Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.